Baliao Acupoint Stimulation toTreat Functional Constipation
Effects and Mechanism of Baliao Acupoint Stimulation (BL31~BL34) for Functional Constipation
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
This study is a randomized controlled trial that explores how a specific acupuncture treatment might help people with functional constipation. The investigators are testing the idea that a treatment called "acupuncture at the Baliao acupoints" could work by changing the way certain parts of the brain connect and function. These brain changes might help improve gut function and relieve constipation symptoms. The investigators will work with people who have functional constipation. Some participants will receive the real Baliao acupoint thread embedding, while others will get a sham acupuncture as a comparison. Using special brain imaging techniques, the investigators will look at how the brain's connections and structures change. The investigators will also track how often participants have bowel movements, the consistency of their stools, and their overall symptoms and quality of life. By comparing these results, the investigators hope to understand how the Baliao acupoint treatment works and why it might be effective for constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedStudy Start
First participant enrolled
June 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
June 8, 2025
June 1, 2025
1 year
May 26, 2025
June 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spontaneous bowel movements
Spontaneous bowel movements (SBMs) refers to the frequency of bowel movements that occur without the use of any medications or other aids within the past 24 hours. These data are collected from the constipation diaries filled out daily by patients with functional constipation (FC) to determine the weekly count of SBMs. The data collection time points include before treatment and at 2, 4, 6, and 8 weeks after treatment.
SBMs will be recorded 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.
Secondary Outcomes (2)
PAC-SYM
PAC-SYM will be assessed at 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment
PAC-QOL
PAC-QOL will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.
Other Outcomes (3)
SAS
SAS will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.
SDS
SDS will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.
Amplitude of Low-Frequency Fluctuations
at 1 week before treatment and 4 weeks after treatment
Study Arms (2)
acupuncture group
EXPERIMENTALPatients will receive acupuncture at Baliao acupuncts.
sham group
SHAM COMPARATORPatients will receive sham acupuncture treatment.
Interventions
Patients will be instructed to lie in the supine position. After strict disinfection of the acupoints area, acupuncture needles will be inserted into the Baliao points (inserted at the surface projections of the first, second, and third pairs of sacral foramina, with a depth of 3-4 cm). The treatment will be administered five times per week, with each session lasting 30 minutes, for a total of two weeks.
Patients will be instructed to lie in the supine position. After strict disinfection of the sham acupoints area, acupuncture needles will be inserted lateral to the surface projections of the first, second, and third pairs of sacral foramina, with a depth of 1 cm.The treatment will be administered five times per week, with each session lasting 30 minutes, for a total of two weeks.
Eligibility Criteria
You may qualify if:
- Age:18 years or older.
- Diagnosed with functional constipation according to the Rome IV criteria.
- The participant has not received any treatment for functional constipation in the past two weeks (except for emergency interventions).
- Right-handed.
- Signed a written informed consent form to participate in this study.
You may not qualify if:
- Presence of organic constipation, drug-induced constipation, or systemic constipation.
- Presence of metallic foreign bodies in the body, pacemakers, or other contraindications for MRI examination.
- Communication disorders or unwillingness to cooperate with treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2025
First Posted
June 8, 2025
Study Start
June 20, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
June 8, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data contains highly sensitive and personal information about study participants. Sharing IPD could potentially compromise participant privacy and confidentiality.